METHOD OF DETERMINING A FINAL NUMERICAL ANALYTE RESULT VALUE CORRESPONDING TO A CONCENTRATION OF AN ANALYTE IN A BODILY FLUID USING A MOBILE DEVICE

(19)

(11)

EP 4 278 967 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.03.2025 Bulletin 2025/10

(45)	Mention of the grant of the patent:
	29.01.2025 Bulletin 2025/05

(21)	Application number: 22174560.7

(22)	Date of filing: 20.05.2022

(51)

International Patent Classification (IPC):

A61B 5/145^(2006.01)
G01N 21/84^(2006.01)

G01N 21/78^(2006.01)
G01N 33/52^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	G01N 21/8483; G01N 21/78; G01N 33/52; A61B 5/14507; G01N 2201/0221

(54)

METHOD OF DETERMINING A FINAL NUMERICAL ANALYTE RESULT VALUE CORRESPONDING TO A CONCENTRATION OF AN ANALYTE IN A BODILY FLUID USING A MOBILE DEVICE

VERFAHREN ZUM BESTIMMEN EINES ENDGÜLTIGEN ANALYTE-RESULTATWERTES, DER EINER KONZENTRATION EINES ANALYTS IN EINER KÖRPERFLÜSSIGKEIT ENTSPRICHT, UNTER VERWENDUNG EINER MOBILEN VORRICHTUNG

PROCÉDÉ DE DÉTERMINATION D'UNE VALEUR NUMÉRIQUE FINALE DU RÉSULTAT DE L'ANALYTE CORRESPONDANT À UNE CONCENTRATION D'UN ANALYTE DANS UN FLUIDE CORPOREL À L'AIDE D'UN DISPOSITIF MOBILE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Validation States:
	MA TN

(43)	Date of publication of application:
	22.11.2023 Bulletin 2023/47

(73)	Proprietors:
	F. Hoffmann-La Roche AG 4070 Basel (CH) Designated Contracting States: AL CH CY CZ ES GB GR HR HU IE IS LI MC MK NO PL RS SK SM TR Roche Diabetes Care GmbH 68305 Mannheim (DE) Designated Contracting States: AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

(72)	Inventors:
	BERG, Max 68305 Mannheim (DE) HAILER, Frederik 68305 Mannheim (DE) HINZMANN, Rolf 68305 Mannheim (DE) LIMBURG, Bernhard 68305 Mannheim (DE)

(74)	Representative: Kierig, Elisabeth
	Roche Diabetes Care GmbH Patent Department Sandhofer Straße 116 68305 Mannheim 68305 Mannheim (DE)

(56)

References cited: :

EP-A1- 3 825 691
WO-A2-2014/025415

WO-A1-2020/260246

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).